• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析血管通路并发症。

The Complications of Vascular Access in Hemodialysis.

机构信息

Department of Medicine, Seton Hall-Hackensack Meridian School of Medicine, Jersey Shore University Medical Center, Neptune, New Jersey.

出版信息

Semin Thromb Hemost. 2018 Feb;44(1):57-59. doi: 10.1055/s-0037-1606180. Epub 2017 Sep 12.

DOI:10.1055/s-0037-1606180
PMID:28898900
Abstract

Complications related to hemodialysis vascular access continue to have a major impact on morbidity and mortality. Vascular access dysfunction is the single most important factor that determines the quality of dialysis treatment. Vascular access stenosis is a common complication that develops in a great majority of patients with an arteriovenous access and leads to access dysfunction. By restricting luminal diameter, this complication leads to a reduction in blood flow and places the access at risk for thrombosis. Similarly, the development of catheter-related fibroepithelial sheath also causes catheter dysfunction with its detrimental effects on blood flow. In this article, we discuss the most common complications associated with dialysis access and provide therapeutic options to manage these problems.

摘要

与血液透析血管通路相关的并发症仍然对发病率和死亡率有重大影响。血管通路功能障碍是决定透析治疗质量的唯一最重要因素。血管通路狭窄是大多数动静脉通路患者中常见的并发症,可导致通路功能障碍。该并发症通过限制管腔直径,导致血流量减少,并使通路容易发生血栓形成。同样,导管相关纤维上皮鞘的发展也会导致导管功能障碍,对血流量产生不利影响。在本文中,我们讨论了与透析通路相关的最常见并发症,并提供了治疗这些问题的选择方案。

相似文献

1
The Complications of Vascular Access in Hemodialysis.血液透析血管通路并发症。
Semin Thromb Hemost. 2018 Feb;44(1):57-59. doi: 10.1055/s-0037-1606180. Epub 2017 Sep 12.
2
Vascular access blood flow monitoring reduces access morbidity and costs.血管通路血流量监测可降低通路相关发病率和成本。
Kidney Int. 2001 Sep;60(3):1164-72. doi: 10.1046/j.1523-1755.2001.0600031164.x.
3
Monitoring dialysis arteriovenous fistulae: it's in our hands.监测透析动静脉内瘘:这掌握在我们手中。
J Vasc Access. 2013 Jul-Sep;14(3):209-15. doi: 10.5301/jva.5000141. Epub 2013 Apr 18.
4
Maintenance of permanent hemodialysis vascular access patency.维持永久性血液透析血管通路的通畅。
ANNA J. 1995 Feb;22(1):17-24.
5
Complications of arteriovenous fistulae: beyond venous stenosis.动静脉瘘并发症:超越静脉狭窄。
Adv Chronic Kidney Dis. 2012 May;19(3):195-201. doi: 10.1053/j.ackd.2012.04.001.
6
[Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?].[对于开始血液透析但没有永久性血管通路的老年人,应选择瘘管还是导管?]
Nefrologia. 2005;25(3):307-14.
7
Stenosis in hemodialysis arteriovenous fistula: evaluation and treatment.血液透析动静脉内瘘狭窄:评估与治疗
Hemodial Int. 2006 Apr;10(2):152-61. doi: 10.1111/j.1542-4758.2006.00087.x.
8
Gene polymorphism association studies in dialysis: vascular access.透析中的基因多态性关联研究:血管通路
Semin Dial. 2007 Jan-Feb;20(1):63-7. doi: 10.1111/j.1525-139X.2007.00243.x.
9
Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis.接受血液透析的系统性红斑狼疮患者发生血管通路血栓形成的风险
J Vasc Access. 2007 Apr-Jun;8(2):103-8.
10
Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies.了解血液透析通路问题的病理生理学,以此作为开发创新疗法的前奏。
Nat Clin Pract Nephrol. 2008 Nov;4(11):628-38. doi: 10.1038/ncpneph0947. Epub 2008 Sep 23.

引用本文的文献

1
Factors associated with patency following drug-coated balloon angioplasty of hemodialysis access.血液透析通路药物涂层球囊血管成形术后通畅性的相关因素。
Sci Rep. 2025 Jun 3;15(1):19375. doi: 10.1038/s41598-025-05133-7.
2
Percutaneous Placement of a Tunneled Permanent Hemodialysis Catheter via the Right Internal Thoracic Vein in a Patient with Exhausted Vascular Access.在血管通路耗竭的患者中经右胸廓内静脉经皮置入带隧道的永久性血液透析导管
Methodist Debakey Cardiovasc J. 2025 Mar 25;21(1):35-38. doi: 10.14797/mdcvj.1494. eCollection 2025.
3
Correlation between β2-microglobulin level and risk of cardiovascular events and prognosis in hemodialysis patients.
血液透析患者β2-微球蛋白水平与心血管事件风险及预后的相关性
Am J Transl Res. 2025 Feb 15;17(2):1428-1436. doi: 10.62347/FLPF7627. eCollection 2025.
4
Risk Factors for Internal Jugular Vein Thrombosis 1 Month After Non-Cuffed Hemodialysis Catheter Removal.非带 cuff 血液透析导管拔除后 1 个月内颈内静脉血栓形成的危险因素。
J Clin Med. 2024 Dec 13;13(24):7579. doi: 10.3390/jcm13247579.
5
Interpretable machine learning models for the prediction of all-cause mortality and time to death in hemodialysis patients.用于预测血液透析患者全因死亡率和死亡时间的可解释机器学习模型。
Ther Apher Dial. 2025 Apr;29(2):220-232. doi: 10.1111/1744-9987.14212. Epub 2024 Sep 26.
6
Myoglobin adsorption and saturation kinetics of the cytokine adsorber Cytosorb® in patients with severe rhabdomyolysis: a prospective trial.细胞因子吸附器Cytosorb®对严重横纹肌溶解症患者的肌红蛋白吸附及饱和动力学:一项前瞻性试验
Ann Intensive Care. 2024 Jun 22;14(1):96. doi: 10.1186/s13613-024-01334-x.
7
Efficacy of Low-Dose Streptokinase Infusion in Late-Onset Permanent Tunnel Catheter Dysfunction: A Single-Center Interventional Study.低剂量链激酶输注治疗迟发性长期隧道式导管功能障碍的疗效:一项单中心干预性研究。
Cureus. 2024 Apr 11;16(4):e58028. doi: 10.7759/cureus.58028. eCollection 2024 Apr.
8
Improving accuracy of vascular access quality classification in hemodialysis patients using deep learning with K highest score feature selection.利用 K 个最高得分特征选择的深度学习提高血液透析患者血管通路质量分类的准确性。
J Int Med Res. 2024 Apr;52(4):3000605241232519. doi: 10.1177/03000605241232519.
9
Successful Removal and Replacement of a Stuck Hemodialysis Catheter via Thoracotomy: Report of Two Cases and Literature Review.经胸廓切开术成功取出并更换嵌顿的血液透析导管:两例报告及文献综述
Case Rep Nephrol Dial. 2024 Apr 3;14(1):56-63. doi: 10.1159/000537740. eCollection 2024 Jan-Dec.
10
Differential expression of serum TM, PAF, and CD62P in patients with autologous arteriovenous fistula and the correlation with vascular access function.血清 TM、PAF 和 CD62P 在自体动静脉瘘患者中的差异表达及其与血管通路功能的相关性。
Immun Inflamm Dis. 2024 Mar;12(3):e1227. doi: 10.1002/iid3.1227.